Simulations Plus Finds China Distributor for R&D Modeling Software

Simulations Plus of California has signed up the Research Institute for Liver Diseases, located in Shanghai, to distribute its pharmaceutical discovery/development simulation and modeling software in China. Simulations calls its products “ in silico consulting services” and positions them as a natural fit for RILD’s in vitro experimental systems. More details.... Stock Symbol: (NSDQ: SLP) Share this with colleagues: // //  
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.